Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni B Migliori

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|October 29, 2011
The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?Keertan Dheda, Giovanni B Migliori
The New England Journal of Medicine|June 14, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisChi Chiu Leung, Giovanni B Migliori
The New England Journal of Medicine|January 4, 2013
History of tuberculosis and drug resistanceGiovanni Sotgiu, Antonio Spanevello, Giovanni B Migliori
The Lancet. Infectious Diseases|November 21, 2016
Time to review treatment of isoniazid-resistant tuberculosis?Lia D'Ambrosio, Giovanni B Migliori, Giovanni Sotgiu
Current Opinion in Pulmonary Medicine|February 21, 2013
Drug-resistant tuberculosisEmanuele Pontali, Alberto Matteelli, Giovanni B Migliori
The New England Journal of Medicine|November 30, 2012
Multidrug-resistant tuberculosisLia D'Ambrosio, Rosella Centis, Giovanni B Migliori
Expert Review of Respiratory Medicine|February 26, 2011
New insights into TB from the 2010 European Respiratory Society annual conferenceRosella Centis, Giovanni B Migliori, Lia D'Ambrosio, et al.
The Lancet. Global Health|October 18, 2020
Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosisKaren H Keddy, Giovanni B Migliori, Martie Van Der Walt
Lancet (London, England)|May 22, 2010
Tuberculosis on the moveHenry M Blumberg, Giovanni B Migliori, Oksana Ponomarenko, et al.
Expert Review of Respiratory Medicine|April 22, 2010
Tuberculosis in Europe: a problem of drug resistance or much more?Anna C C Carvalho, Giovanni B Migliori, Daniela M Cirillo
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|October 29, 2011
The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?Keertan Dheda, Giovanni B Migliori
The New England Journal of Medicine|June 14, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisChi Chiu Leung, Giovanni B Migliori
The New England Journal of Medicine|January 4, 2013
History of tuberculosis and drug resistanceGiovanni Sotgiu, Antonio Spanevello, Giovanni B Migliori
The Lancet. Infectious Diseases|November 21, 2016
Time to review treatment of isoniazid-resistant tuberculosis?Lia D'Ambrosio, Giovanni B Migliori, Giovanni Sotgiu
Current Opinion in Pulmonary Medicine|February 21, 2013
Drug-resistant tuberculosisEmanuele Pontali, Alberto Matteelli, Giovanni B Migliori
The New England Journal of Medicine|November 30, 2012
Multidrug-resistant tuberculosisLia D'Ambrosio, Rosella Centis, Giovanni B Migliori
Expert Review of Respiratory Medicine|February 26, 2011
New insights into TB from the 2010 European Respiratory Society annual conferenceRosella Centis, Giovanni B Migliori, Lia D'Ambrosio, et al.
The Lancet. Global Health|October 18, 2020
Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosisKaren H Keddy, Giovanni B Migliori, Martie Van Der Walt
Lancet (London, England)|May 22, 2010
Tuberculosis on the moveHenry M Blumberg, Giovanni B Migliori, Oksana Ponomarenko, et al.
Expert Review of Respiratory Medicine|April 22, 2010
Tuberculosis in Europe: a problem of drug resistance or much more?Anna C C Carvalho, Giovanni B Migliori, Daniela M Cirillo
Pageof 4